KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1436 |
|---|---|
| Product Name | Anti-Human CD279 Recombinant Antibody(Camrelizumab) |
| Molecular Name | Camrelizumab |
| Alias | Anti-CD279 Recombinant Antibody, Research Grade Camrelizumab |
| CAS Number | 1798286-48-2 |
| Target | CD279[Homo sapiens] |
| Isotype | IgG4 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | ELISA, IHC, IF, IP, FCM, Block |
| Buffer | PBS, pH7.5 |
| Background | Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitionitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
